Centogene NV

-0.10 (-2.06%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)106.53M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$31.91 Million
Adjusted EPS-$0.84
See more estimates
10-Day MA$4.75
50-Day MA$6.23
200-Day MA$9.42
See more pivots

Centogene NV Stock, NASDAQ:CNTG

Am Strande 7, Rostock, Mecklenburg-Vorpommern 18055
Phone: +49.381.80113400
Number of Employees: 657


Centogene NV is a commercial-stage company, which focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following segments: Pharmaceutical, Diagnostics, and Corporate. The Pharmaceutical segment provides solutions to pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, and biomarker discovery. The Diagnostics segment offers genetic sequencing and diagnostics services to clients, who are typically physicians, laboratories, or hospitals, either directly or through distributors. The Other segment covers COVID-19 testing services to clients. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.